Skip to content
DraconiticResearch
Search Sources API
226,742 studies31 sourcesUpdated 42 min ago
Peer-reviewedCC BY-NC-ND 4.0Clinical Epigenetics

Unraveling the complexities of cardiorenal syndrome: epigenetic and post-translational modification perspectives

4 affiliations
  1. 1Cardiovascular Disease Center, The Central Hospital of Enshi Tujia and Miao Autonomous Prefecture, Enshi, Hubei Province China
  2. 2Hubei Selenium and Human Health Institute, The Central Hospital of Enshi Tujia and Miao Autonomous Prefecture, Enshi, Hubei Province China
  3. 3Hubei Provincial Key Lab of Selenium Resources and Bio Applications, Enshi, Hubei Province China
  4. 4Cardiovascular Disease Center, The Central Hospital of Enshi Tujia and Miao Autonomous Prefecture, Hubei Minzu University, Enshi, Hubei Province China

Abstract

Cardiorenal syndrome (CRS) is a complex condition where heart and kidney dysfunctions interact, leading to high morbidity and mortality. It presents significant challenges in cardiovascular and renal medicine due to its prevalence and severe outcomes. Traditional models focus on hemodynamic issues, renin–angiotensin–aldosterone system activation, oxidative stress, and inflammation but fall short in explaining CRS's chronic and varied nature. Recent research in epigenomics and proteomics highlights the importance of epigenetic regulation and post-translational modifications (PTMs) in CRS development. Epigenetics provides stable, long-term gene regulation related to diseases without changing the DNA sequence, mainly through DNA methylation, histone modification, and non-coding RNA regulation. In contrast, PTMs quickly alter protein function and signaling via ubiquitination, phosphorylation, acetylation, and newer processes like lactoylation and carbamylation. Both play key roles in CRS by affecting inflammation, fibrosis, and mitochondrial dysfunction, and are linked through a complex regulatory network. This review details the mechanisms and interactions between epigenetics and PTMs in CRS, emphasizing their potential as biomarkers and therapeutic targets, and discusses research limitations and future directions to advance understanding.

Related

  1. ProCAS: Multi-Lysine Post-Translational Modification Site Prediction Based on the SPUS Algorithm and the ProCAS Architecture
    Yun Zuo, Li Zhou, Xingze Fang +3
    Molecular & Cellular ProteomicsPeer-reviewedCC BY-NC-ND 4.0Full textMolecular biology & gene regulationCrossref
  2. Hypoxia alters the synthesis and post-translational modification of collagens in human coronary artery smooth muscle cells
    Sara M. Jørgensen, Karen C. Yang-Jensen, Lasse G. Lorentzen +4
    Journal of Biological ChemistryPeer-reviewedCC BY 4.0Molecular biology & gene regulationCrossref
  3. Optimized Super-SILAC Normalization Enables Enhanced Profiling of Histone Post-Translational Modification Changes Associated with Microbiota and Acute Inflammation
    Dieggo Rodrigues de Paula, Alessandro Vai, Roberta Noberini +5
    Molecular & Cellular ProteomicsPeer-reviewedLicence not statedProteomics & metabolomicsCrossref
  4. Direct regulation of a tRNA modification enzyme by ppGpp links stress signaling to translational control and biofilm development
    Aude E. Trinquier, Franck Slama, Junlang Liu +3
    Science AdvancesPeer-reviewedCC BY 4.0Full textGeneral biochemistryMicrobiologySci. Adv.CrossrefPMC
  5. Modulating the NLRP3/IL-1β Axis in Age-Related Atherosclerosis: Natural Products, Molecular Mechanisms, and Translational Perspectives—A Narrative Review
    BiomoleculesPeer-reviewedCC BYFull textGeneral biochemistryEurope PMC
BibTeX
@article{chen2026unraveling,
  title = {{Unraveling the complexities of cardiorenal syndrome: epigenetic and post-translational modification perspectives}},
  author = {Xin Chen and Haotian Huang and Tiantian Zhang and Lu Ye and Dan Luo and Yuhua Lei and Rui Huang},
  journal = {Clinical Epigenetics},
  year = {2026},
  month = aug,
  doi = {10.1186/s13148-026-02225-7},
  url = {https://doi.org/10.1186/s13148-026-02225-7},
  note = {CC BY-NC-ND 4.0},
}
RIS
TY  - JOUR
TI  - Unraveling the complexities of cardiorenal syndrome: epigenetic and post-translational modification perspectives
AU  - Xin Chen
AU  - Haotian Huang
AU  - Tiantian Zhang
AU  - Lu Ye
AU  - Dan Luo
AU  - Yuhua Lei
AU  - Rui Huang
PY  - 2026
DA  - 2026/08/12
JO  - Clinical Epigenetics
DO  - 10.1186/s13148-026-02225-7
UR  - https://doi.org/10.1186/s13148-026-02225-7
AB  - Cardiorenal syndrome (CRS) is a complex condition where heart and kidney dysfunctions interact, leading to high morbidity and mortality. It presents significant challenges in cardiovascular and renal medicine due to its prevalence and severe outcomes. Traditional models focus on hemodynamic issues, renin–angiotensin–aldosterone system activation, oxidative stress, and inflammation but fall short in explaining CRS's chronic and varied nature. Recent research in epigenomics and proteomics highlights the importance of epigenetic regulation and post-translational modifications (PTMs) in CRS development. Epigenetics provides stable, long-term gene regulation related to diseases without changing the DNA sequence, mainly through DNA methylation, histone modification, and non-coding RNA regulation. In contrast, PTMs quickly alter protein function and signaling via ubiquitination, phosphorylation, acetylation, and newer processes like lactoylation and carbamylation. Both play key roles in CRS by affecting inflammation, fibrosis, and mitochondrial dysfunction, and are linked through a complex regulatory network. This review details the mechanisms and interactions between epigenetics and PTMs in CRS, emphasizing their potential as biomarkers and therapeutic targets, and discusses research limitations and future directions to advance understanding.
SN  - 1868-7075
SN  - 1868-7083
ER  -